Preclinical Biopharmaceuticals

Our research focuses on the development of new drugs for the treatment of colon cancer, metabolic and neurodegenerative diseases.

VIEW CONTENT

Main Technology

Extraction of bioactive compounds, antioxidant, anti-proliferative and anti-inflammatory characterisation and potentiation of their effects using nanotechnology. As a result, we hold several patents with applications in the biomedical industry.

WHAT HAVE WE DISCOVERED

Our R&D Projects

Pre-clinical validation of NPS functionalised with EUPHORBIA LATHYRIX biomolecules as a novel targeted therapy for advanced CRC

Preclinical validation of NPS functionalised with EUPHORBIA LATHYRIX biomolecules as a new selective therapy for advanced CRC Project focused on advancing the preclinical validation of a new treatment for advanced colorectal cancer based on the use of a complex of biomimetic nanoparticles linked to biomolecules from ethanolic extracts of Euphorbia lathyris that has a high and selective antitumour activity against this type of tumour.

Participating entities

Project funded by the Instituto de Salud Carlos III and the Centro de Desarrollo Tecnológico Industrial in the joint action programme for innovations in personalised medicine and advanced therapies.

Resolution granted under PMPTA22/00136 or IDI-20230073.

Plant-based nano-pharmaceuticals with anti-tumour activity against colon cancer

Project focused on obtaining functional extracts derived from solanaceae, cucurbits and legumes, which can be used, individually or in combination, for the preparation of nanodrugs with applications in the prevention and/or treatment of colon cancer.

Participating entities

Project funded by the RETOS Collaboration Programme 2017, with EU ERDF funds managed by the Ministry of Science, Innovation and Universities of the Government of Spain.

Resolution granted under file number RTC-2017-6540-1.

Valorisation of waste derived from fruit and vegetable crops to obtain nutraceuticals active in colon cancer and metabolic syndrome.

Project focused on obtaining functional extracts that can be used, individually or in combination, for the prevention and/or treatment of colon cancer and metabolic syndrome.

Participating entities

Project financed by the RETOS Collaboration 2019 Programme, with EU ERDF funds managed by the Ministry of Science, Innovation and Universities of the Government of Spain.

Resolution granted under file number RTC2019-006870-1.

Brassiceuticals

Project focused on the identification and isolation of bioactive components present in different plants of the brassica genus, and the evaluation of their nutraceutical capacity in the prevention of different types of cancer and metabolic syndrome.

Collaborating entity

Collaborating entityProject funded by the State Programme Doctors Torres Quevedo 2018 for the Promotion of Talent and its Employability in R&D&I, managed by the Ministry of Science, Innovation and Universities of the Government of Spain.

Resolution granted under file number RTC-2017-6540-1.

Discover the Future

We are a biotechnology company committed to the discovery of efficient and effective bioactive principles as pharmaceuticals, nutraceuticals or useful in the field of plant biology.

Contact us